Bulletin
Investor Alert

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 22, 2021, 4:38 p.m.

/zigman2/quotes/203556943/composite

$

34.60

Change

0.00 0.00%

Volume

Volume 12,807

Quotes are delayed by 20 min

/zigman2/quotes/203556943/composite

Previous close

$ 34.04

$ 34.60

Change

+0.56 +1.65%

Day low

Day high

$30.47

$34.65

Open

52 week low

52 week high

$26.20

$68.40

Open

Annual Financials for Deciphera Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue ---25M42.09M
Cost of Goods Sold (COGS) incl. D&A 90,000150,000317,000-5.36M
COGS excluding D&A ----225,000
Depreciation & Amortization Expense 90,000150,000317,000830,0005.14M
Depreciation 90,000150,000317,000830,0005.14M
Amortization of Intangibles -----
Gross Income (90,000)(150,000)(317,000)-36.72M
20162017201820192020 5-year trend
SG&A Expense 25.75M50.79M103.78M224.9M307.91M
Research & Development 20.16M39.51M82.89M156.78M196.67M
Other SG&A 5.59M11.27M20.9M68.12M111.25M
Other Operating Expense -----
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense 4,000746,0004.33M8.54M4.7M
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense 106,00095,00084,00067,000-
Gross Interest Expense 106,00095,00084,00067,000-
Interest Capitalized -----
Pretax Income (25.94M)(50.28M)(99.85M)(192.26M)(266.49M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (25.94M)(50.28M)(99.85M)(192.26M)(266.49M)
Minority Interest Expense -----
Net Income (25.94M)(50.28M)(99.85M)(192.26M)(266.49M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (25.94M)(50.28M)(99.85M)(192.26M)(266.49M)
Preferred Dividends -----
Net Income Available to Common (25.94M)(50.28M)(99.85M)(192.26M)(266.49M)
EPS (Basic) (0.78)(2.99)(2.82)(4.48)(4.78)
Basic Shares Outstanding 33.05M16.79M35.39M42.87M55.78M
EPS (Diluted) (0.78)(2.99)(2.82)(4.48)(4.78)
Diluted Shares Outstanding 33.05M16.79M35.39M42.87M55.78M
EBITDA (25.75M)(50.79M)(103.78M)(199.9M)(266.05M)
Link to MarketWatch's Slice.